Laryngoscope investigative otolaryngology · 2025
Obstacles to Obtain Care Among Sexual and Gender Minorities With Chronic Rhinosinusitis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Khan Faizaan I, Khan Najm S, Majeethia Heli, Park Jihwan, Dongre Roshan, Wu Franklin, Brissett Ella, Takashima Masayoshi, Ahmed Omar G
Аннотация
OBJECTIVES: This study aims to compare the prevalence of cost and non-cost barriers to healthcare access among sexual and gender minority (SGM) patients and non-SGM patients with chronic rhinosinusitis (CRS).
METHODS: The All of Us Research Program was queried for CRS patients, defined as having at least two diagnoses of chronic sinusitis (ICD10: J32.x). Patients were categorized based on questions regarding gender identity, biological sex, and self-descriptions. The primary outcome was cost and non-cost barriers. Multivariable logistic regression was used to examine SGM status and experiencing barriers to care.
RESULTS: 7708 patients with CRS were included; 595 were SGM and 7113 were non-SGM. SGM patients were significantly more likely to delay primary care (AOR: 1.51, 95% CI: 1.09-2.11), specialist care (AOR: 1.54, 95% CI: 1.18-2.00), mental healthcare (AOR: 1.70, 95% CI: 1.29-2.24), and filling prescription medication (AOR: 1.31, 95% CI: 1.03-1.66). Regarding non-cost barriers, SGM patients were significantly more likely to delay care because of transportation problems (AOR: 1.84, 95% CI: 1.39-2.42), their provider having a different background (AOR: 1.48, 95% CI: 1.14-1.90) and due to a lack of respect by their providers (AOR: 1.42, 95% CI: 1.16-1.73).
CONCLUSION: SGM patients with CRS report multiple cost and non-cost barriers. While differences between CRS and non-CRS groups were modest, rhinologists and other healthcare practitioners treating SGM patients with CRS should be mindful of these disparities to address these barriers at a patient and system level.
LEVEL OF EVIDENCE: Level III, 2025.
METHODS: The All of Us Research Program was queried for CRS patients, defined as having at least two diagnoses of chronic sinusitis (ICD10: J32.x). Patients were categorized based on questions regarding gender identity, biological sex, and self-descriptions. The primary outcome was cost and non-cost barriers. Multivariable logistic regression was used to examine SGM status and experiencing barriers to care.
RESULTS: 7708 patients with CRS were included; 595 were SGM and 7113 were non-SGM. SGM patients were significantly more likely to delay primary care (AOR: 1.51, 95% CI: 1.09-2.11), specialist care (AOR: 1.54, 95% CI: 1.18-2.00), mental healthcare (AOR: 1.70, 95% CI: 1.29-2.24), and filling prescription medication (AOR: 1.31, 95% CI: 1.03-1.66). Regarding non-cost barriers, SGM patients were significantly more likely to delay care because of transportation problems (AOR: 1.84, 95% CI: 1.39-2.42), their provider having a different background (AOR: 1.48, 95% CI: 1.14-1.90) and due to a lack of respect by their providers (AOR: 1.42, 95% CI: 1.16-1.73).
CONCLUSION: SGM patients with CRS report multiple cost and non-cost barriers. While differences between CRS and non-CRS groups were modest, rhinologists and other healthcare practitioners treating SGM patients with CRS should be mindful of these disparities to address these barriers at a patient and system level.
LEVEL OF EVIDENCE: Level III, 2025.